Follicle-stimulating Hormones Market Size, Share, and Industry Analysis, By Treatment (Recombinant FSH and Urinary FSH), By Treatment Type (Infertility Treatment and Assisted Reproductive Technology), By End User (Hospitals and Fertility Centers), and Regional Forecast, 2026-2034

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content:

1. Introduction
   1. Research Scope
   2. Market Segmentation
   3. Research Methodology
   4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   1. Market Drivers
   2. Market Restraints
   3. Market Opportunities
   4. Market Trends
4. Key Insights
   1. Prevalence of Infertility, By Key Countries, 2023
   2. Number of Fertility Centers, By Key Countries, 2023
   3. Number of IVF Procedures, By Key Countries, 2023
   4. Key Industry Developments, By Key Players
   5. Impact of COVID-19 on the Market
5. Global Follicle-Stimulating Hormones Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights, and Forecast – By Type
      1. Recombinant FSH
      2. Urinary FSH
   2. Market Analysis, Insights, and Forecast – By Application
      1. Infertility Treatment
      2. Assisted Reproductive Technology
   3. Market Analysis, Insights, and Forecast – By End User
      1. Hospitals
      2. Fertility Centers
   4. Market Analysis, Insights, and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
6. North America Follicle-Stimulating Hormones Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights, and Forecast – By Type
      1. Recombinant FSH
      2. Urinary FSH
   2. Market Analysis, Insights, and Forecast – By Application
      1. Infertility Treatment
      2. Assisted Reproductive Technology
   3. Market Analysis, Insights, and Forecast – By End User
      1. Hospitals
      2. Fertility Centers
   4. Market Analysis, Insights, and Forecast – By Country
      1. U.S.
      2. Canada
7. Europe Follicle-Stimulating Hormones Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights, and Forecast – By Type
      1. Recombinant FSH
      2. Urinary FSH
   2. Market Analysis, Insights, and Forecast – By Application
      1. Infertility Treatment
      2. Assisted Reproductive Technology
   3. Market Analysis, Insights, and Forecast – By End User
      1. Hospitals
      2. Fertility Centers
   4. Market Analysis, Insights, and Forecast – By Country/Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
8. Asia Pacific Follicle-Stimulating Hormones Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights, and Forecast – By Type
      1. Recombinant FSH
      2. Urinary FSH
   2. Market Analysis, Insights, and Forecast – By Application
      1. Infertility Treatment
      2. Assisted Reproductive Technology
   3. Market Analysis, Insights, and Forecast – By End User
      1. Hospitals
      2. Fertility Centers
   4. Market Analysis, Insights, and Forecast – By Country/Sub-Region
      1. China
      2. India
      3. Japan
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
9. Latin America Follicle-Stimulating Hormones Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights, and Forecast – By Type
      1. Recombinant FSH
      2. Urinary FSH
   2. Market Analysis, Insights, and Forecast – By Application
      1. Infertility Treatment
      2. Assisted Reproductive Technology
   3. Market Analysis, Insights, and Forecast – By End User
      1. Hospitals
      2. Fertility Centers
   4. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
10. Middle East & Africa Follicle-Stimulating Hormones Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights, and Forecast – By Type
       1. Recombinant FSH
       2. Urinary FSH
    2. Market Analysis, Insights, and Forecast – By Application
       1. Infertility Treatment
       2. Assisted Reproductive Technology
    3. Market Analysis, Insights, and Forecast – By End User
       1. Hospitals
       2. Fertility Centers
    4. Market Analysis, Insights and Forecast – By Country/Sub-Region
       1. South Africa
       2. GCC
       3. Rest of Middle East & Africa
11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
       1. Intas Pharmaceuticals Ltd
       2. Organon group of companies
       3. Merck KGaA
       4. LG Chem
       5. Ferring Pharmaceuticals
       6. Merck & Co., Inc.
       7. Lupin
       8. Mankind
       9. Other Prominent Players